In other words, our present results implicate that the Andrographolide-induced inhibition on NHE1 activity/expression does not only highly correlate with the inhibition on viability and migration, but also more specific/sensitive to human cervical cancer cells than human normal cervical cells (Figure 5, Figure 6 and Figure 7). This evidence concerns the gene SLC9A1 and cervical cancer.